CellaVision AB (publ) (STO:CEVI)
Sweden · Delayed Price · Currency is SEK 157.20
0.00 (0.00%)
At close: Dec 30, 2025
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 3.75 billion as of December 31, 2025. Its market cap has decreased by -27.56% in one year.
Market Cap
3.75B
Enterprise Value
3.62B
Revenue
748.45M
Ranking
n/a
PE Ratio
24.76
Stock Price
157.20
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 3.75B, an increase of 907.67%. That is a compound annual growth rate of 13.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 3.75B | -27.72% |
| Dec 30, 2024 | 5.19B | 2.59% |
| Dec 29, 2023 | 5.06B | -7.42% |
| Dec 30, 2022 | 5.46B | -29.58% |
| Dec 30, 2021 | 7.76B | 5.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.70B |
| Getinge AB | 59.59B |
| Sectra AB | 48.36B |
| Camurus AB | 36.74B |
| Medicover AB | 33.29B |
| Asker Healthcare Group AB | 32.33B |
| BioArctic AB | 27.55B |
| Elekta AB | 21.68B |